Herein, we for the first time discovered the up-regulation of A20 in melanoma, and proved that A20 was a novel oncogenic factor for melanoma via the simultaneous contribution to tumor growth and metastasis, demonstrating the great potential of A20 as a valuable therapeutic target. This evidence concerns the gene TNFAIP3 and melanoma.